Role of ChatGPT in Vestibular Schwannoma Management

Status Not yet recruiting

Clinical Trial Summary

Previous studies have demonstrated that patients frequently undergo significant decision conflict regarding major medical decisions in otolaryngology. There lack validated tools available for decision support for patients. While limited evidence has demonstrated that clinical decision support tools can alleviate decision conflict for patients with diagnosis in otolaryngology, conversational language models were not employed in these studies and may provide additional benefit in this context. This study seeks to evaluate the efficacy of using ChatGPT, a conversational language model with basic clinical knowledge, in alleviating decision conflict for patients with new diagnosis in otolaryngology. For this pilot study, vestibular schwannoma, a benign tumor that develops on the vestibular nerve with known clinical equipoise, has been chosen for the initial study diagnosis. Efficacy will be evaluated by comparison of responses to the Decisional Conflict Scale (DCS) and Satisfaction with Decision (SWD) scores between a group given training in ChatGPT and a control group (no ChatGPT training).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06163664
Study type	Interventional
Source	University of Southern California
Contact
Status	Not yet recruiting
Phase	N/A
Start date	December 15, 2024
Completion date	November 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04196933` - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma	N/A
Active, not recruiting	`NCT00973739` - Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors	Phase 2
Completed	`NCT04351373` - Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560	Phase 2
Active, not recruiting	`NCT01449604` - Stereotactic Radiation in Vestibular Schwannoma	Phase 3
Completed	`NCT01207687` - Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)	Phase 2
Not yet recruiting	`NCT05567341` - Remote Ischemic Preconditioning in Vestibular Schwannoma Surgery	N/A
Completed	`NCT02249572` - Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.	N/A
Terminated	`NCT05116878` - Enhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma	N/A
Suspended	`NCT03095248` - Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors	Phase 2
Recruiting	`NCT04801953` - Nimodipine in Vestibular Schwanommas	Phase 2
Recruiting	`NCT03745560` - Intraoperative EABR for Decision Making
Recruiting	`NCT04859335` - Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma	N/A
Recruiting	`NCT04128345` - Novel Multimodality Imaging for Navigation in Skull Base Surgery
Active, not recruiting	`NCT01199978` - Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma	Phase 2
Recruiting	`NCT04057976` - Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas	N/A
Completed	`NCT00863122` - Concentration and Activity of Lapatinib in Vestibular Schwannomas	Early Phase 1
Recruiting	`NCT04374305` - Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)	Phase 2
Recruiting	`NCT03079999` - Study of Aspirin in Patients With Vestibular Schwannoma	Phase 2
Recruiting	`NCT05786144` - Vestibular Schwannoma Organoids
Recruiting	`NCT03593577` - Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI